2025 · 4th Quarter (Oct 1 - Dec 31)

PRIO PHARMA, INC.

Filed by ACTUM I, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Termination
Posted: Jan 21, 2026
Income: $10,000.00
Expenses: Not reported
Registrant: ACTUM I, LLC
Client: PRIO PHARMA, INC.
Filing UUID: d4d1203c-f5e6-4a3b-942d-f5a54f5542da
Termination date: Dec 31, 2025

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY26 Defense Appropriations bill - Defense Health Program funding; H.R.5371 - Continuing Appropriations and Extensions Act, 2026, S.2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026; FY2026 Continuing Appropriations, Agriculture, Leg. Branch & Extensions Act P.L. 119-37

Literal federal measure citations: H.R.5371, S.2882

DEF · Defense

FY26 Defense Appropriations bill - Defense Health Program funding; FY26 National Defense Authorization Act (P.L. 119-60)

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.